Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Genetic risk factors for hypertrophic scar development.

Thompson CM, Hocking AM, Honari S, Muffley LA, Ga M, Gibran NS.

J Burn Care Res. 2013 Sep-Oct;34(5):477-82. doi: 10.1097/BCR.0b013e3182a2aa41.

2.

Race and Melanocortin 1 Receptor Polymorphism R163Q Are Associated with Post-Burn Hypertrophic Scarring: A Prospective Cohort Study.

Sood RF, Hocking AM, Muffley LA, Ga M, Honari S, Reiner AP, Rowhani-Rahbar A, Gibran NS.

J Invest Dermatol. 2015 Oct;135(10):2394-401. doi: 10.1038/jid.2015.197. Epub 2015 Jun 1.

3.

Genome-wide Association Study of Postburn Scarring Identifies a Novel Protective Variant.

Sood RF, Hocking AM, Muffley LA, Ga M, Honari S, Reiner AP, Gibran NS.

Ann Surg. 2015 Oct;262(4):563-9. doi: 10.1097/SLA.0000000000001439.

PMID:
26366535
4.

Missense Variant in MAPK Inactivator PTPN5 Is Associated with Decreased Severity of Post-Burn Hypertrophic Scarring.

Sood RF, Arbabi S, Honari S, Gibran NS.

PLoS One. 2016 Feb 12;11(2):e0149206. doi: 10.1371/journal.pone.0149206. eCollection 2016.

5.

What score on the Vancouver Scar Scale constitutes a hypertrophic scar? Results from a survey of North American burn-care providers.

Thompson CM, Sood RF, Honari S, Carrougher GJ, Gibran NS.

Burns. 2015 Nov;41(7):1442-8. doi: 10.1016/j.burns.2015.04.018. Epub 2015 Jul 2.

6.

Prospective, before-after cohort study to assess the efficacy of laser therapy on hypertrophic burn scars.

Hultman CS, Edkins RE, Wu C, Calvert CT, Cairns BA.

Ann Plast Surg. 2013 May;70(5):521-6. doi: 10.1097/SAP.0b013e31827eac5e.

PMID:
23542846
7.

Epidemiology and impact of scarring after burn injury: a systematic review of the literature.

Lawrence JW, Mason ST, Schomer K, Klein MB.

J Burn Care Res. 2012 Jan-Feb;33(1):136-46. doi: 10.1097/BCR.0b013e3182374452. Review.

PMID:
22138807
8.

Tumor necrosis factor gene variation and the risk of mortality after burn injury: a cohort study.

Shalhub S, Pham TN, Gibran NS, O'keefe GE.

J Burn Care Res. 2009 Jan-Feb;30(1):105-11. doi: 10.1097/BCR.0b013e3181921f60.

9.

Topical silicone gel versus placebo in promoting the maturation of burn scars: a randomized controlled trial.

van der Wal MB, van Zuijlen PP, van de Ven P, Middelkoop E.

Plast Reconstr Surg. 2010 Aug;126(2):524-31. doi: 10.1097/PRS.0b013e3181e09559.

PMID:
20679835
10.

Ten year experience of burn, trauma, and combined burn/trauma injuries comparing outcomes.

Santaniello JM, Luchette FA, Esposito TJ, Gunawan H, Reed RL, Davis KA, Gamelli RL.

J Trauma. 2004 Oct;57(4):696-700; dicussion 700-1.

PMID:
15514521
11.

Laser resurfacing and remodeling of hypertrophic burn scars: the results of a large, prospective, before-after cohort study, with long-term follow-up.

Hultman CS, Friedstat JS, Edkins RE, Cairns BA, Meyer AA.

Ann Surg. 2014 Sep;260(3):519-29; discussion 529-32. doi: 10.1097/SLA.0000000000000893. Erratum in: Ann Surg. 2015 Apr;261(4):811.

PMID:
25115428
12.

Risk factors for the development of heterotopic ossification in seriously burned adults: A National Institute on Disability, Independent Living and Rehabilitation Research burn model system database analysis.

Levi B, Jayakumar P, Giladi A, Jupiter JB, Ring DC, Kowalske K, Gibran NS, Herndon D, Schneider JC, Ryan CM.

J Trauma Acute Care Surg. 2015 Nov;79(5):870-6. doi: 10.1097/TA.0000000000000838.

13.

Predictors of Discharge Disposition in Older Adults With Burns: A Study of the Burn Model Systems.

Pham TN, Carrougher GJ, Martinez E, Lezotte D, Rietschel C, Holavanahalli R, Kowalske K, Esselman PC.

J Burn Care Res. 2015 Nov-Dec;36(6):607-12. doi: 10.1097/BCR.0000000000000216.

PMID:
26492549
14.

Formation of hypertrophic scars: evolution and susceptibility.

Mahdavian Delavary B, van der Veer WM, Ferreira JA, Niessen FB.

J Plast Surg Hand Surg. 2012 Apr;46(2):95-101. doi: 10.3109/2000656X.2012.669184.

PMID:
22471257
15.

Late outcomes after grafting of the severely burned face: a quality improvement initiative.

Philp L, Umraw N, Cartotto R.

J Burn Care Res. 2012 Jan-Feb;33(1):46-56. doi: 10.1097/BCR.0b013e318234d89f.

PMID:
22002207
16.

Changes in subjective vs objective burn scar assessment over time: does the patient agree with what we think?

Martin D, Umraw N, Gomez M, Cartotto R.

J Burn Care Rehabil. 2003 Jul-Aug;24(4):239-44; discussion 238.

PMID:
14501421
17.

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.

Ulrich D, Ulrich F, Unglaub F, Piatkowski A, Pallua N.

J Plast Reconstr Aesthet Surg. 2010 Jun;63(6):1015-21. doi: 10.1016/j.bjps.2009.04.021. Epub 2009 May 22.

PMID:
19464975
18.

Tissue expansion for correction of scars due to burn and other causes: a retrospective comparative study of various complications.

Fochtmann A, Keck M, Mittlböck M, Rath T.

Burns. 2013 Aug;39(5):984-9. doi: 10.1016/j.burns.2012.10.020. Epub 2012 Dec 28.

PMID:
23276651
19.

Challenging the dogma: relationship between time to healing and formation of hypertrophic scars after burn injuries.

Hassan S, Reynolds G, Clarkson J, Brooks P.

J Burn Care Res. 2014 Mar-Apr;35(2):e118-24. doi: 10.1097/BCR.0b013e31829b330a.

PMID:
23877141
20.

Genetic susceptibility to keloid disease and hypertrophic scarring: transforming growth factor beta1 common polymorphisms and plasma levels.

Bayat A, Bock O, Mrowietz U, Ollier WE, Ferguson MW.

Plast Reconstr Surg. 2003 Feb;111(2):535-43; discussion 544-6.

PMID:
12560674

Supplemental Content

Support Center